Use of PET/MR Imaging in Chronic Pain
Launched by STANFORD UNIVERSITY · Jun 20, 2017
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The diagnosis and management of chronic and neuropathic pain syndromes remains a major clinical challenge, and this failure is partly attributed to our inability to identify the hypersensitive and inflammatory changes in the pain-sensing part of our nervous system that is thought to contribute to these syndromes. The lack of a specific, objective diagnostic test for chronic and neuropathic pain syndromes can result in a delay of diagnosis and suboptimal management decisions. This delay in diagnosis is quite unfortunate since the early diagnosis and treatment of a disease is attributed to th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older.
- • Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica, complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy, osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- • Provides informed consent
- • On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- • Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
- Exclusion Criteria:
- • MRI-incompatible
- • Diabetes
- • Pregnant or nursing
- • Non-English speaker
- • Claustrophobic
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Feliks Kogan, PhD
Principal Investigator
Assistant Professor of Radiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials